![PDF) The effect of optic neuritis treatment trial (ONTT) combined corticosteroid regimen on pattern reversal visual evoked potentials: a prospective follow-up study PDF) The effect of optic neuritis treatment trial (ONTT) combined corticosteroid regimen on pattern reversal visual evoked potentials: a prospective follow-up study](https://i1.rgstatic.net/publication/354393023_The_effect_of_optic_neuritis_treatment_trial_ONTT_combined_corticosteroid_regimen_on_pattern_reversal_visual_evoked_potentials_a_prospective_follow-up_study/links/6136f52f38818c2eaf88500e/largepreview.png)
PDF) The effect of optic neuritis treatment trial (ONTT) combined corticosteroid regimen on pattern reversal visual evoked potentials: a prospective follow-up study
![Population-based Incidence of Pediatric and Adult Optic Neuritis and the Risk of Multiple Sclerosis - Ophthalmology Population-based Incidence of Pediatric and Adult Optic Neuritis and the Risk of Multiple Sclerosis - Ophthalmology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/111433bc-2df7-4ef3-bd50-26da2db70bba/gr1.jpg)
Population-based Incidence of Pediatric and Adult Optic Neuritis and the Risk of Multiple Sclerosis - Ophthalmology
![Intravenous methylprednisolone versus oral prednisone for initial attacks of optic neuritis, A review of evidence - Philippine Journal Of Ophthalmology Intravenous methylprednisolone versus oral prednisone for initial attacks of optic neuritis, A review of evidence - Philippine Journal Of Ophthalmology](https://paojournal.com/wp-content/uploads/2019/06/14-1-300x213.png)
Intravenous methylprednisolone versus oral prednisone for initial attacks of optic neuritis, A review of evidence - Philippine Journal Of Ophthalmology
![Safety and efficacy of erythropoietin for the treatment of patients with optic neuritis (TONE): a randomised, double-blind, multicentre, placebo-controlled study - The Lancet Neurology Safety and efficacy of erythropoietin for the treatment of patients with optic neuritis (TONE): a randomised, double-blind, multicentre, placebo-controlled study - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/32306741-97bb-44cb-ad44-0342ab151bab/gr1_lrg.gif)
Safety and efficacy of erythropoietin for the treatment of patients with optic neuritis (TONE): a randomised, double-blind, multicentre, placebo-controlled study - The Lancet Neurology
![Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis? | Neurology Neuroimmunology & Neuroinflammation Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis? | Neurology Neuroimmunology & Neuroinflammation](https://nn.neurology.org/sites/default/files/highwire/nnn/6/4/e572/embed/inline-graphic-1.gif)
Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis? | Neurology Neuroimmunology & Neuroinflammation
![Amiloride Clinical Trial In Optic Neuritis (ACTION) protocol: a randomised, double blind, placebo controlled trial | BMJ Open Amiloride Clinical Trial In Optic Neuritis (ACTION) protocol: a randomised, double blind, placebo controlled trial | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/5/11/e009200/F2.large.jpg)
Amiloride Clinical Trial In Optic Neuritis (ACTION) protocol: a randomised, double blind, placebo controlled trial | BMJ Open
![Comparison of central and peripheral visual field properties in the Optic Neuritis Treatment Trial - American Journal of Ophthalmology Comparison of central and peripheral visual field properties in the Optic Neuritis Treatment Trial - American Journal of Ophthalmology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d1b9b8dd-d440-4bed-a0a3-ea13053a171c/gr2.gif)
Comparison of central and peripheral visual field properties in the Optic Neuritis Treatment Trial - American Journal of Ophthalmology
![Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial - The Lancet Neurology Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2095258808/2077467364/gr1.gif)